Factorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine

scientific article published on 10 August 2019

Factorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/PHARMACEUTICS11080401
P932PMC publication ID6722980
P698PubMed publication ID31405159

P50authorJoana A. LoureiroQ51836976
Maria do Carmo PereiraQ51836998
Maria João RamalhoQ64880671
P2093author name stringManuel A N Coelho
P2860cites workCurrent Challenges and Opportunities in Treating Glioblastoma.Q52579808
Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatmentQ88532378
Biophysical interaction of temozolomide and its active metabolite with biomembrane models: The relevance of drug-membrane interaction for Glioblastoma Multiforme therapyQ91223988
Interaction of natural compounds with biomembrane models: A biophysical approach for the Alzheimer's disease therapyQ91569726
Temozolomide resistance in glioblastoma multiformeQ91792247
The effect of nanoparticle size on in vivo pharmacokinetics and cellular interactionQ38784932
Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluationQ38791773
PLGA nanoparticles as a platform for vitamin D-based cancer therapyQ38850543
Nano-structures mediated co-delivery of therapeutic agents for glioblastoma treatment: A reviewQ38950420
High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterizationQ39629382
Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticlesQ41881058
A Fractional Factorial Design to Study the Effect of Process Variables on the Preparation of Hyaluronidase Loaded PLGA NanoparticlesQ42042782
Polymeric nanoparticles loaded with the 3,5,3'-triiodothyroacetic acid (Triac), a thyroid hormone: factorial design, characterization, and release kinetics.Q42055713
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierQ42153590
Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design.Q43245104
Enhanced sonocatalysis of textile wastewater using bentonite-supported ZnO nanoparticles: Response surface methodological approach.Q43349072
Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptakeQ44054856
Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiencyQ46675585
Nanoparticles for multi-modality cancer diagnosis: Simple protocol for self-assembly of gold nanoclusters mediated by gadolinium ions.Q48881697
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant gliomaQ24644727
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performanceQ33578774
Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterisationQ33776038
Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder CancerQ34479313
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium studyQ36455403
Principles of nanoparticle design for overcoming biological barriers to drug deliveryQ37162182
The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cellsQ37190466
Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting-Ideal Versus RealityQ37290850
PLGA-based nanoparticles: an overview of biomedical applications.Q37986980
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticlesQ38059207
Statistical approaches to maximize recombinant protein expression in Escherichia coli: a general reviewQ38161273
Optimization of methazolamide-loaded solid lipid nanoparticles for ophthalmic delivery using Box-Behnken designQ38194593
Posttranslational Regulation of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and New Opportunities for Treatment of Brain Cancers.Q38552355
Transmission Electron Microscopy as a Tool for the Characterization of Soft Materials: Application and Interpretation.Q38678664
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P577publication date2019-08-10
P1433published inPharmaceuticsQ27723332
P1476titleFactorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine
P478volume11

Search more.